Global and United States Dasatinib Drugs Market Report & Forecast 2023-2028

Report ID: 1840837 | Published Date: Jan 2025 | No. of Page: 76 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Dasatinib Drugs Product Introduction
    1.2 Global Dasatinib Drugs Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Dasatinib Drugs Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Dasatinib Drugs Sales in Volume for the Year 2017-2028
    1.3 United States Dasatinib Drugs Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Dasatinib Drugs Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Dasatinib Drugs Sales in Volume for the Year 2017-2028
    1.4 Dasatinib Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Dasatinib Drugs in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Dasatinib Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Dasatinib Drugs Market Dynamics
        1.5.1 Dasatinib Drugs Industry Trends
        1.5.2 Dasatinib Drugs Market Drivers
        1.5.3 Dasatinib Drugs Market Challenges
        1.5.4 Dasatinib Drugs Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Dasatinib Drugs Market Segment by Type
        2.1.1 20mg
        2.1.2 50mg
        2.1.3 70mg
    2.2 Global Dasatinib Drugs Market Size by Type
        2.2.1 Global Dasatinib Drugs Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Dasatinib Drugs Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Dasatinib Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Dasatinib Drugs Market Size by Type
        2.3.1 United States Dasatinib Drugs Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Dasatinib Drugs Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Dasatinib Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Dasatinib Drugs Market Segment by Application
        3.1.1 CML
        3.1.2 ALL
    3.2 Global Dasatinib Drugs Market Size by Application
        3.2.1 Global Dasatinib Drugs Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Dasatinib Drugs Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Dasatinib Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Dasatinib Drugs Market Size by Application
        3.3.1 United States Dasatinib Drugs Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Dasatinib Drugs Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Dasatinib Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Dasatinib Drugs Competitor Landscape by Company
    4.1 Global Dasatinib Drugs Market Size by Company
        4.1.1 Top Global Dasatinib Drugs Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Dasatinib Drugs Revenue by Manufacturer (2017-2022)
        4.1.3 Global Dasatinib Drugs Sales by Manufacturer (2017-2022)
        4.1.4 Global Dasatinib Drugs Price by Manufacturer (2017-2022)
    4.2 Global Dasatinib Drugs Concentration Ratio (CR)
        4.2.1 Dasatinib Drugs Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Dasatinib Drugs in 2021
        4.2.3 Global Dasatinib Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Dasatinib Drugs Manufacturing Base Distribution, Product Type
        4.3.1 Global Dasatinib Drugs Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Dasatinib Drugs Product Type
        4.3.3 Date of International Manufacturers Enter into Dasatinib Drugs Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Dasatinib Drugs Market Size by Company
        4.5.1 Top Dasatinib Drugs Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Dasatinib Drugs Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Dasatinib Drugs Sales by Players (2020, 2021 & 2022)
5 Global Dasatinib Drugs Market Size by Region
    5.1 Global Dasatinib Drugs Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Dasatinib Drugs Market Size in Volume by Region (2017-2028)
        5.2.1 Global Dasatinib Drugs Sales in Volume by Region: 2017-2022
        5.2.2 Global Dasatinib Drugs Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Dasatinib Drugs Market Size in Value by Region (2017-2028)
        5.3.1 Global Dasatinib Drugs Sales in Value by Region: 2017-2022
        5.3.2 Global Dasatinib Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Dasatinib Drugs Market Size YoY Growth 2017-2028
        6.1.2 North America Dasatinib Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Dasatinib Drugs Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Dasatinib Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Dasatinib Drugs Market Size YoY Growth 2017-2028
        6.3.2 Europe Dasatinib Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Dasatinib Drugs Market Size YoY Growth 2017-2028
        6.4.2 Latin America Dasatinib Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Dasatinib Drugs Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Dasatinib Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 Bristol-Myers Squibb
        7.1.1 Bristol-Myers Squibb Corporation Information
        7.1.2 Bristol-Myers Squibb Description and Business Overview
        7.1.3 Bristol-Myers Squibb Dasatinib Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Bristol-Myers Squibb Dasatinib Drugs Products Offered
        7.1.5 Bristol-Myers Squibb Recent Development
    7.2 LUCIUS Pharma
        7.2.1 LUCIUS Pharma Corporation Information
        7.2.2 LUCIUS Pharma Description and Business Overview
        7.2.3 LUCIUS Pharma Dasatinib Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 LUCIUS Pharma Dasatinib Drugs Products Offered
        7.2.5 LUCIUS Pharma Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Dasatinib Drugs Industry Chain Analysis
    8.2 Dasatinib Drugs Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Dasatinib Drugs Distributors
    8.3 Dasatinib Drugs Production Mode & Process
    8.4 Dasatinib Drugs Sales and Marketing
        8.4.1 Dasatinib Drugs Sales Channels
        8.4.2 Dasatinib Drugs Distributors
    8.5 Dasatinib Drugs Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Dasatinib Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Dasatinib Drugs Market Trends
    Table 3. Dasatinib Drugs Market Drivers
    Table 4. Dasatinib Drugs Market Challenges
    Table 5. Dasatinib Drugs Market Restraints
    Table 6. Global Dasatinib Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Dasatinib Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Dasatinib Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Dasatinib Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Dasatinib Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Dasatinib Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Dasatinib Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Dasatinib Drugs Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Dasatinib Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Dasatinib Drugs Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Dasatinib Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Dasatinib Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dasatinib Drugs as of 2021)
    Table 18. Top Players of Dasatinib Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Dasatinib Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Dasatinib Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Dasatinib Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Dasatinib Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Dasatinib Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Dasatinib Drugs Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Dasatinib Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Dasatinib Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Dasatinib Drugs Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Dasatinib Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Dasatinib Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Dasatinib Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Dasatinib Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Dasatinib Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Dasatinib Drugs Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Dasatinib Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Dasatinib Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Dasatinib Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Dasatinib Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Dasatinib Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Dasatinib Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Dasatinib Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Bristol-Myers Squibb Corporation Information
    Table 43. Bristol-Myers Squibb Description and Business Overview
    Table 44. Bristol-Myers Squibb Dasatinib Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Bristol-Myers Squibb Dasatinib Drugs Product
    Table 46. Bristol-Myers Squibb Recent Development
    Table 47. LUCIUS Pharma Corporation Information
    Table 48. LUCIUS Pharma Description and Business Overview
    Table 49. LUCIUS Pharma Dasatinib Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. LUCIUS Pharma Product
    Table 51. LUCIUS Pharma Recent Development
    Table 52. Key Raw Materials Lists
    Table 53. Raw Materials Key Suppliers Lists
    Table 54. Dasatinib Drugs Customers List
    Table 55. Dasatinib Drugs Distributors List
    Table 56. Research Programs/Design for This Report
    Table 57. Key Data Information from Secondary Sources
    Table 58. Key Data Information from Primary Sources
List of Figures
    Figure 1. Dasatinib Drugs Product Picture
    Figure 2. Global Dasatinib Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Dasatinib Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Dasatinib Drugs Sales 2017-2028 (K Units)
    Figure 5. United States Dasatinib Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Dasatinib Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Dasatinib Drugs Sales 2017-2028 (K Units)
    Figure 8. United States Dasatinib Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Dasatinib Drugs Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Dasatinib Drugs Report Years Considered
    Figure 11. Product Picture of 20mg
    Figure 12. Product Picture of 50mg
    Figure 13. Product Picture of 70mg
    Figure 14. Global Dasatinib Drugs Market Share by Type in 2022 & 2028
    Figure 15. Global Dasatinib Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Dasatinib Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Dasatinib Drugs Sales by Type (2017-2028) & (K Units)
    Figure 18. Global Dasatinib Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Dasatinib Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 20. United States Dasatinib Drugs Market Share by Type in 2022 & 2028
    Figure 21. United States Dasatinib Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Dasatinib Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Dasatinib Drugs Sales by Type (2017-2028) & (K Units)
    Figure 24. United States Dasatinib Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Dasatinib Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 26. Product Picture of CML
    Figure 27. Product Picture of ALL
    Figure 28. Global Dasatinib Drugs Market Share by Application in 2022 & 2028
    Figure 29. Global Dasatinib Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Dasatinib Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Dasatinib Drugs Sales by Application (2017-2028) & (K Units)
    Figure 32. Global Dasatinib Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Dasatinib Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 34. United States Dasatinib Drugs Market Share by Application in 2022 & 2028
    Figure 35. United States Dasatinib Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Dasatinib Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Dasatinib Drugs Sales by Application (2017-2028) & (K Units)
    Figure 38. United States Dasatinib Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Dasatinib Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 40. North America Dasatinib Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 41. North America Dasatinib Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. U.S. Dasatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Dasatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe Dasatinib Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 45. Europe Dasatinib Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany Dasatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France Dasatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. U.K. Dasatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy Dasatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia Dasatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific Dasatinib Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 52. Asia-Pacific Dasatinib Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China Dasatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan Dasatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea Dasatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India Dasatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia Dasatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Taiwan Dasatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Dasatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Dasatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Dasatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Philippines Dasatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Dasatinib Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 64. Latin America Dasatinib Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Dasatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Dasatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Dasatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Dasatinib Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 69. Middle East & Africa Dasatinib Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Dasatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Dasatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. UAE Dasatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Dasatinib Drugs Value Chain
    Figure 74. Dasatinib Drugs Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bristol-Myers Squibb
LUCIUS Pharma
Frequently Asked Questions
Dasatinib Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Dasatinib Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Dasatinib Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Sprycel

Sprycel market is segmented by region (country), players, by Type and by Application. Players, st ... Read More

Xatmep

Xatmep market is segmented by region (country), players, by Type and by Application. Players, sta ... Read More